NEW YORK (GenomeWeb News) – BGI and Portuguese startup Coimbra Genomics today announced a project to investigate the genetic basis of gastric cancer, the second most common cause of cancer after lung cancer.

The project is initially being funded with $900,000 and will involve researchers from the Institute of Molecular Pathology and Immunology at the University of Porto in Portugal, or IPATIMUP, a cancer research institute with "a particularly strong track record [in] gastric cancer," the partners said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.